185 related articles for article (PubMed ID: 6523344)
21. [Results of combined treatment of advanced forms of multiple myeloma with vincristine, melphalan, cyclophosphamide and prednisone (VMCP) and with vincristine, doxorubicin, cyclophosphamide and prednisone (VDCP)].
Robak T; Krykowski E; Płuzańska A; Olszańska-Skorek T; Urbańska-Ryś H; Polkowska-Kulesza E; Błasińska-Morawiec M; Mazurowa A
Pol Tyg Lek; 1983 Apr; 38(16):481-4. PubMed ID: 6579509
[No Abstract] [Full Text] [Related]
22. Conventional chemotherapy in multiple myeloma.
Westin J
Pathol Biol (Paris); 1999 Feb; 47(2):169-71. PubMed ID: 10192883
[TBL] [Abstract][Full Text] [Related]
23. [Current status and prospects of the clinical chemotherapy of tumorous diseases].
Perevodchikova NI
Vestn Akad Med Nauk SSSR; 1986; (5):3-8. PubMed ID: 2425507
[No Abstract] [Full Text] [Related]
24. [High-dose melphalan in patients with multiple myeloma].
Moreau P; Le Bonniec M; Harousseau JL
Bull Cancer; 1999 Mar; 86(3):283-8. PubMed ID: 10210762
[TBL] [Abstract][Full Text] [Related]
25. [Are drug combinations useful in multiple myeloma?].
Pavlovsky S
Sangre (Barc); 1984; 29(5):872-5. PubMed ID: 6523339
[No Abstract] [Full Text] [Related]
26. Multiple myeloma in the era of novel agents.
Dimopoulos MA; Attal M
Semin Hematol; 2009 Apr; 46(2):107-9. PubMed ID: 19389493
[No Abstract] [Full Text] [Related]
27. Clinical outcomes in t(4;14) multiple myeloma: a chemotherapy-sensitive disease characterized by rapid relapse and alkylating agent resistance.
Jaksic W; Trudel S; Chang H; Trieu Y; Qi X; Mikhael J; Reece D; Chen C; Stewart AK
J Clin Oncol; 2005 Oct; 23(28):7069-73. PubMed ID: 16129840
[TBL] [Abstract][Full Text] [Related]
28. Vincristine, BCNU, doxorubicin, and prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group study.
Bonnet J; Alexanian R; Salmon S; Bottomley R; Amare M; Haut A; Dixon D
Cancer Treat Rep; 1982 Jun; 66(6):1267-71. PubMed ID: 7044534
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic strategies and controversies in the treatment of multiple myeloma.
Bladé J
Pathol Biol (Paris); 1999 Feb; 47(2):192-8. PubMed ID: 10192888
[TBL] [Abstract][Full Text] [Related]
30. Update on recent developments for patients with newly diagnosed multiple myeloma.
Palumbo A; Magarotto V; Gay F; Falco P; Bringhen S; Boccadoro M
Ann N Y Acad Sci; 2008 Sep; 1138():19-21. PubMed ID: 18837878
[TBL] [Abstract][Full Text] [Related]
31. The therapeutic efficacy of VBCMP-M2 protocol in multiple myeloma.
Colović MD; Janković GM; Nikolov VS; Suvajdzić ND; Miletić VD
Haematologia (Budap); 1994; 26(2):91-6. PubMed ID: 7890267
[TBL] [Abstract][Full Text] [Related]
32. IgD multiple myeloma. A report of three cases.
Martini R; Santini S; Bottari G
Minerva Med; 1996 Mar; 87(3):109-12. PubMed ID: 8668286
[TBL] [Abstract][Full Text] [Related]
33. [Multiple myeloma and other plasma cell dyscrasias].
del Potro Gómez E; Morales Sanz D
Rev Clin Esp; 1999 Apr; 199 Suppl 1():52-7. PubMed ID: 10422451
[No Abstract] [Full Text] [Related]
34. Refractory multiple myeloma treated with homoharringtonine: report of two cases.
Yang X; Yang C; Shao K; Ye X; Meng H; Zhou Y; Qian W
Ann Hematol; 2007 Dec; 86(12):919-21. PubMed ID: 17641891
[No Abstract] [Full Text] [Related]
35. Combo drug therapy beneficial for new cases of multiple myeloma.
Health News; 2006 Feb; 12(2):9. PubMed ID: 16456922
[No Abstract] [Full Text] [Related]
36. [Plasmocytic pleural effusion disclosing multiple myeloma].
Elloumi M; Frikha M; Masmoudi H; Mseddi S; Ben Ayed M; Bouaziz M; Makni F; Souissi T
Rev Mal Respir; 2000 Apr; 17(2):495-7. PubMed ID: 10859769
[TBL] [Abstract][Full Text] [Related]
37. [Long-term fever and light-chain myeloma].
Gripenberg M
Duodecim; 1995; 111(4):345-7. PubMed ID: 8654302
[No Abstract] [Full Text] [Related]
38. [Multiple myeloma: ambulatory chemotherapy--nursing care techniques].
Houis P; Jubert-Leleu MC
Soins; 1994 Oct; (589):28, 30-3. PubMed ID: 7676293
[No Abstract] [Full Text] [Related]
39. Frontline treatment of multiple myeloma in elderly patients.
Moreau P; Hulin C; Facon T
Blood Rev; 2008 Nov; 22(6):303-9. PubMed ID: 18550234
[TBL] [Abstract][Full Text] [Related]
40. [Characteristics of drug resistance of tumor plasmocytes in vitro in patients with multiple myeloma differently responsive to chemotherapy].
Golenkov AK; Trifonova EV; Kataeva EV; Kil'diushevskiĭ AV; Lutskaia TD; Zariad'eva EA; Nazarova IN; Lukashina MN; Zabotina TN; Mikhaĭlova IN; Inshakov AN; Logacheva NP; Baryshnikov AIu
Ter Arkh; 2000; 72(8):38-41. PubMed ID: 11019426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
